1 - 25 of 36 results for author:"Kamat A." in Literature citations
Results Customize
› Repeat search in UniProtKB (72,502)
| Role of beta-adrenergic receptors in regulation of hepatic fat accumulation during aging. Ghosh P.M., Shu Z.J., Zhu B., Lu Z., Ikeno Y., Barnes J.L., Yeh C.K., Zhang B.X., Katz M.S., Kamat A. J. Endocrinol. 213:251-261(2012) · Mapped (3) |
| Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes. Zhang H.M., Dang H., Kamat A., Yeh C.K., Zhang B.X. PLoS ONE 7:e32746-e32746(2012) · Mapped (6) |
| A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Garcia-Closas M., Ye Y., Rothman N., Figueroa J.D., Malats N., Dinney C.P., Chatterjee N., Prokunina-Olsson L., Wang Z., Lin J. et al. Hum. Mol. Genet. 20:4282-4289(2011) · Mapped (9) |
| De novo deletion of chromosome 20q13.33 in a patient with tracheo-esophageal fistula, cardiac defects and genitourinary anomalies implicates GTPBP5 as a candidate gene. Solomon B.D., Pineda-Alvarez D.E., Hadley D.W., Keaton A.A., Agochukwu N.B., Raam M.S., Carlson-Donohoe H.E., Kamat A., Chandrasekharappa S.C. Birth Defects Res. Part A Clin. Mol. Teratol. 91:862-865(2011) · Mapped (5) |
| Analysis of FOXF1 and the FOX gene cluster in patients with VACTERL association. Agochukwu N.B., Pineda-Alvarez D.E., Keaton A.A., Warren-Mora N., Raam M.S., Kamat A., Chandrasekharappa S.C., Solomon B.D. Eur J Med Genet 54:323-328(2011) · Mapped (1) |
| Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Merritt W.M., Kamat A.A., Hwang J.Y., Bottsford-Miller J., Lu C., Lin Y.G., Coffey D., Spannuth W.A., Nugent E., Han L.Y. et al. Cancer Biol. Ther. 10:1306-1314(2010) · Mapped (5) |
| Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. Sood A.K., Armaiz-Pena G.N., Halder J., Nick A.M., Stone R.L., Hu W., Carroll A.R., Spannuth W.A., Deavers M.T., Allen J.K. et al. J. Clin. Invest. 120:1515-1523(2010) · Mapped (12) |
| Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A. Shashidharamurthy R., Zhang F., Amano A., Kamat A., Panchanathan R., Ezekwudo D., Zhu C., Selvaraj P. J. Immunol. 183:8216-8224(2009) · Mapped (2) |
| Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. Etemad B., Fellows A., Kwambana B., Kamat A., Feng Y., Lee S., Sagar M. J. Virol. 83:9694-9708(2009) · Mapped (5) |
| Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk. Lin J., Kamat A., Gu J., Chen M., Dinney C.P., Forman M.R., Wu X. Cancer Epidemiol. Biomarkers Prev. 18:2090-2097(2009) · Mapped (20) |
| Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta. Kumar P., Kamat A., Mendelson C.R. Mol. Endocrinol. 23:784-793(2009) · Mapped (67) |
| Dicer, Drosha, and outcomes in patients with ovarian cancer. Merritt W.M., Lin Y.G., Han L.Y., Kamat A.A., Spannuth W.A., Schmandt R., Urbauer D., Pennacchio L.A., Cheng J.F., Nick A.M. et al. N. Engl. J. Med. 359:2641-2650(2008) · Mapped (9) |
| 1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. Inamoto T., Papineni S., Chintharlapalli S., Cho S.D., Safe S., Kamat A.M. Mol. Cancer Ther. 7:3825-3833(2008) · Mapped (3) |
| Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Merritt W.M., Lin Y.G., Spannuth W.A., Fletcher M.S., Kamat A.A., Han L.Y., Landen C.N., Jennings N., De Geest K., Langley R.R. et al. J. Natl. Cancer Inst. 100:359-372(2008) · Mapped (1) |
| Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Kamat A.A., Merritt W.M., Coffey D., Lin Y.G., Patel P.R., Broaddus R., Nugent E., Han L.Y., Landen C.N. Jr., Spannuth W.A. et al. Clin. Cancer Res. 13:7487-7495(2007) · Mapped (7) |
| Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Halder J., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Honda T., Kamat A.A., Han L.Y., Kim T.J., Lu C. et al. Cancer Res. 67:10976-10983(2007) · UniProtKB (1) |
| High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Chen M., Kamat A.M., Huang M., Grossman H.B., Dinney C.P., Lerner S.P., Wu X., Gu J. Carcinogenesis 28:2160-2165(2007) · Mapped (17) |
| Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., Kamat A.A., Spannuth W.A., Gershenson D.M., Lutgendorf S.K. et al. Clin. Cancer Res. 13:3423-3430(2007) · Mapped (3) |
| Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences. Mikkelsen T.S., Wakefield M.J., Aken B., Amemiya C.T., Chang J.L., Duke S., Garber M., Gentles A.J., Goodstadt L., Heger A. et al. Nature 447:167-177(2007) · UniProtKB (22,167) |
| Relaxin promotes prostate cancer progression. Feng S., Agoulnik I.U., Bogatcheva N.V., Kamat A.A., Kwabi-Addo B., Li R., Ayala G., Ittmann M.M., Agoulnik A.I. Clin. Cancer Res. 13:1695-1702(2007) · Mapped (2) |
| EphA2 overexpression is associated with angiogenesis in ovarian cancer. Lin Y.G., Han L.Y., Kamat A.A., Merritt W.M., Landen C.N., Deavers M.T., Fletcher M.S., Urbauer D.L., Kinch M.S., Sood A.K. Cancer 109:332-340(2007) · Mapped (5) |
| Analysis of EphA2 expression and mutant p53 in ovarian carcinoma. Merritt W.M., Thaker P.H., Landen C.N. Jr., Deavers M.T., Fletcher M.S., Lin Y.G., Han L.Y., Kamat A.A., Schmandt R., Gershenson D.M. et al. Cancer Biol. Ther. 5:1357-1360(2006) · Mapped (37) |
| Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma. Han L.Y., Landen C.N., Trevino J.G., Halder J., Lin Y.G., Kamat A.A., Kim T.J., Merritt W.M., Coleman R.L., Gershenson D.M. et al. Cancer Res. 66:8633-8639(2006) · Mapped (3) |
| Analysis of the DNA sequence and duplication history of human chromosome 15. Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A. et al. Nature 440:671-675(2006) · UniProtKB (2,293) |
| The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Kamat A.A., Fletcher M., Gruman L.M., Mueller P., Lopez A., Landen C.N. Jr., Han L., Gershenson D.M., Sood A.K. Clin. Cancer Res. 12:1707-1714(2006) · Mapped (7) |